ask="49.35"
ask_size="100"
average_daily_volume="1128930"
bid="45.50"
bid_size="200"
book_value="10.71"
change="+0.30"
change_from_200_day_moving_average="-4.57"
change_from_50_day_moving_average="4.21"
change_from_52_week_high="-33.86"
change_From_52_week_low="14.87"
change_in_percent="+0.65%"
close="46.25"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.79"
ebitda="-409.46M"
eps_estimate_current_year="-5.09"
eps_estimate_next_quarter="-1.30"
eps_estimate_next_year="-4.74"
ex_dividend_date="N/A"
float_shares="71056000"
high="46.94"
high_52_weeks="80.11"
last_trade_date="2/23/2017"
last_trade_price="46.25"
last_trade_size="53615"
last_trade_time="4:00pm"
low="45.67"
low_52_weeks="31.38"
market_capitalization="3.98B"
moving_average_200_day="50.82"
moving_average_50_day="42.04"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="62.73"
open="46.12"
pe_ratio="N/A"
peg_ratio="-0.20"
percent_change_from_200_day_moving_average="-9.00%"
percent_change_from_50_day_moving_average="+10.01%"
percent_change_from_52_week_high="-42.27%"
percent_change_from_52_week_low="+47.39%"
previous_close="45.95"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.29"
price_per_sales="83.81"
revenue="47.16M"
shares_outstanding="86013000"
short_ratio="10.08"
stock_exchange="NMS"
symbol="ALNY"
volume="607000"
weeks_range_52="31.38 - 80.11"
